Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-008021
Filing Date
2025-05-20
Accepted
2025-05-20 16:15:35
Documents
49
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 10-K bzyr-20250228x10k.htm   iXBRL 10-K 1163242
2 EX-19.1 bzyr-20250228xex19d1.htm EX-19.1 79069
3 EX-31.1 bzyr-20250228xex31d1.htm EX-31.1 12124
4 EX-31.2 bzyr-20250228xex31d2.htm EX-31.2 11904
5 EX-32.1 bzyr-20250228xex32d1.htm EX-32.1 7231
6 EX-32.2 bzyr-20250228xex32d2.htm EX-32.2 7276
  Complete submission text file 0001558370-25-008021.txt   3676606

Data Files

Seq Description Document Type Size
7 EX-101.SCH bzyr-20250228.xsd EX-101.SCH 31896
8 EX-101.CAL bzyr-20250228_cal.xml EX-101.CAL 20421
9 EX-101.DEF bzyr-20250228_def.xml EX-101.DEF 80629
10 EX-101.LAB bzyr-20250228_lab.xml EX-101.LAB 232978
11 EX-101.PRE bzyr-20250228_pre.xml EX-101.PRE 159337
52 EXTRACTED XBRL INSTANCE DOCUMENT bzyr-20250228x10k_htm.xml XML 321105
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 25968979
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)